Results 81 to 90 of about 555,914 (187)

Effects of Drug Resistance on the Global Spread of Malaria: A Systematic Literature Review

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Malaria remains a major health crisis in tropical regions, with Sub‐Saharan Africa bearing the heaviest burden. While insecticide‐treated nets and artemisinin‐based combination therapies (ACTs) have reduced cases, emerging parasite resistance to artemisinin threatens these gains. This review synthesizes evidence on how drug
Ashenafi Woldemichael Woime
wiley   +1 more source

Review of contextual factors related to seasonal malaria chemoprevention

, 2022
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.3 Seasonal malaria chemoprevention (SMC)” of the WHO Guidelines for malaria, 3 June 2022.
Bhattarai A, Thwing J, Williamson J, Cavros I, Gutman J   +4 more
openaire   +2 more sources

Additional file 1 of Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso

, 2022
Additional file 1: Figure S1. Monthly trends of uncomplicated malaria incidence in health districts before and after SMC implementation among older age group (5–14 years old and 15 years and more). Figure S2. Monthly trends of severe malaria incidence in
Mady Ouédraogo (6062639), Yazoumé Yé (32191), Arnold Fottsoh Fokam (12513707), Vincent De Brouwere (685436), Fati Kirakoya-Samadoulougou (3531539)   +4 more
core   +1 more source

Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach

Malaria Journal, 2023
Abstract Background SMC was adopted in Nigeria in 2014 and by 2021 was being implemented in 18 states, over four months between June and October by 143000 community drug distributors (CDDs) to a target population of 23million children. Further expansion of SMC is planned, extending to 21 states
Nnenna Ogbulafor, Perpetua Uhomoibhi, Emmanuel Shekarau, Jamilu Nikau, Chukwu Okoronkwo, Nadia M. L. Fanou, Ibrahima Marietou Mbaye, Jean-Louis Ndiaye, Andre-Marie Tchouatieu, Abena Poku-Awuku, Corinne Merle, Susana Scott, Paul Milligan, Aminu Ali, Hauwa’u Evelyn Yusuf, Stephen Oguche, Tukur Dahiru   +16 more
openaire   +3 more sources

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria

Malaria Journal, 2021
Background Malaria and malnutrition remain major problems in Sahel countries, especially in young children. The direct effect of malnutrition on malaria remains poorly understood, and may have important implications for malaria control.
Mariken de Wit, Matthew Cairns, Yves Daniel Compaoré, Issaka Sagara, Irene Kuepfer, Issaka Zongo, Amadou Barry, Modibo Diarra, Amadou Tapily, Samba Coumare, Ismaila Thera, Frederic Nikiema, R. Serge Yerbanga, Rosemonde M. Guissou, Halidou Tinto, Alassane Dicko, Daniel Chandramohan, Brian Greenwood, Jean Bosco Ouedraogo   +18 more
doaj   +1 more source

A 5‐Year Retrospective Morbidity Profile of School‐Aged Children at Ho Polyclinic, Volta Region, Ghana: Skin Conditions, Malaria, and Respiratory Illnesses as Leading Causes (2018–2022)

Public Health Challenges, Volume 5, Issue 3, September 2026.
Analysis of 10,428 outpatient consultations among school‐aged children attending Ho Polyclinic, Ghana (2018–2022), showed that three conditions accounted for 77.4% of all morbidity: skin conditions (38.3%), malaria (23.0%), and respiratory conditions (16.1%).
Anthoinette Adesope Ekuban, Frank Baiden
wiley   +1 more source

Geostatistical Modelling and Web‐Based Mapping of Malaria Risks Among Children Under Five Years in Nigeria: Evidence From the 2021 Nigeria Malaria Indicator Survey

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Malaria is a critical public health concern in Nigeria with the country bearing an uneven burden of the disease. In Nigeria, malaria is one of the main causes of child mortality and despite all efforts to reduce malaria mortality rates, the disease remains a major concern, notably among children under‐fives.
Justice Moses K. Aheto, Bakare Emmanuel Afolabi, Dolapo O. Oniyelu, Deborah O. Daniel, Steven I. Ikediashi, Oluwaseun A. Mogbojuri, Ronke D. Olorunfemi, Sodiq A. Orogun, Afeez Abidemi, Idowu I. Olasupo, Samuel A. Osikoya, Samuel A. Adeyemi, Hapiness O. Ismail, Isaac Bakare, Samson O. Olagbami, Dolapo A. Bakare, Baiyeri Samuel, Temitayo V. Irewole, Oluwafunmilayo O. Olapade, Oluwafolakemi Odunola, Oghenekevwe R. Ajewole, Joshua P. Ojo, Segun Oyedeji, Wisdom Takramah   +23 more
wiley   +1 more source

Making the most of malaria chemoprevention

Malaria Journal
Against a backdrop of stalled progress in malaria control, it is surprising that the various forms of malaria chemoprevention are not more widely used. The World Health Organization (WHO) has recommended several malaria chemoprevention strategies, some ...
Jasper Littmann, Dorothy Achu, Miriam K. Laufer, Corine Karema, David Schellenberg   +4 more
doaj   +1 more source

Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020

Malaria Journal, 2022
Background In 2012, the World Health Organization (WHO) recommended seasonal malaria chemoprevention (SMC) in areas of high seasonal transmission. Though implemented since 2013, the effectiveness of SMC in Togo was never evaluated.
Tchaa A. Bakai, Anne Thomas, Jean Iwaz, Tinah Atcha-Oubou, Tchassama Tchadjobo, Nagham Khanafer, Muriel Rabilloud, Nicolas Voirin   +7 more
doaj   +1 more source

Quantitative and Clinical Pharmacology Perspectives on Next‐Generation Malaria Prevention Using Vaccines and Long‐Acting Monoclonal Antibodies

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Malaria remains a significant global health burden, particularly among pediatric populations in endemic regions. Recent advances in preventive interventions highlight the complementary roles of vaccines and long‐acting monoclonal antibodies (mAbs) in reducing infection risk.
Sabiha R. Mim, Leonardo C. Xavier, Francine J. Azeredo, Sihem Ait‐Oudhia   +3 more
wiley   +1 more source